Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction

被引:120
作者
Bello, Natalie A. [1 ]
Claggett, Brian [1 ]
Desai, Akshay S. [1 ]
McMurray, John J. V. [2 ]
Granger, Christopher B. [3 ]
Yusuf, Salim [4 ,5 ]
Swedberg, Karl [6 ]
Pfeffer, Marc A. [1 ]
Solomon, Scott D. [1 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, Dept Med, Boston, MA 02115 USA
[2] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[3] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA
[4] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada
[5] McMaster Univ, Hamilton, ON, Canada
[6] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden
基金
美国国家卫生研究院;
关键词
clinical trials; heart failure; hospitalization; outcomes assessment; VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; MYOCARDIAL-INFARCTION; STATIN THERAPY; MORTALITY; CANDESARTAN; MORBIDITY; TRENDS; PREVALENCE; PROGNOSIS;
D O I
10.1161/CIRCHEARTFAILURE.113.001281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Hospitalization for acute heart failure (HF) is associated with high rates of subsequent mortality and readmission. We assessed the influence of the time interval between previous HF hospitalization and randomization in the Candesartan in Heart failure: Reduction in Mortality and morbidity (CHARM) trials on clinical outcomes in patients with both reduced and preserved ejection fraction. Methods and Results-CHARM enrolled 7599 patients with New York Heart Association class II to IV HF, of whom 5426 had a history of previous HF hospitalization. Cox proportional hazards regression models were used to assess the association between time from previous HF hospitalization and randomization and the primary outcome of cardiovascular death or unplanned admission to hospital for the management of worsening HF during a median of 36.6 months. For patients with HF and reduced or preserved ejection fraction, rates of cardiovascular mortality and HF hospitalization were higher among patients with previous HF hospitalization than those without. The risk for mortality and hospitalization varied inversely with the time interval between hospitalization and randomization. Rates were higher for patients with HF and reduced ejection fraction within each category. Event rates for those with HF with preserved ejection fraction and a HF hospitalization in the 6 months before randomization were comparable with the rate in patients with HF and reduced ejection fraction with no previous HF hospitalization. Conclusions-Rates of cardiovascular death or HF hospitalization are greatest in those who have been previously hospitalized for HF. Independent of EF, rates of death and readmission decline as time from HF hospitalization to trial enrollment increased. Recent HF hospitalization identifies a high-risk population for future clinical trials in HF and reduced ejection fraction and HF with preserved ejection fraction.
引用
收藏
页码:590 / 595
页数:6
相关论文
共 31 条
[1]  
Antman EM, 2001, CIRCULATION, V103, pE101
[2]   Heart failure with preserved left ventricular systolic function: a hospital cohort study [J].
Berry, C ;
Hogg, K ;
Norrie, J ;
Stevenson, K ;
Brett, M ;
McMurray, J .
HEART, 2005, 91 (07) :907-913
[3]   Outcome of heart failure with preserved ejection fraction in a population-based study [J].
Bhatia, R. Sacha ;
Tu, Jack V. ;
Lee, Douglas S. ;
Austin, Peter C. ;
Fang, Jiming ;
Haouzi, Annick ;
Gong, Yanyan ;
Liu, Peter P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03) :260-269
[4]   Systolic and diastolic heart failure in the community [J].
Bursi, Francesca ;
Weston, Susan A. ;
Redfield, Margaret M. ;
Jacobsen, Steven J. ;
Pakhomov, Serguei ;
Nkomo, Vuyisile T. ;
Meverden, Ryan A. ;
Roger, Veronique L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (18) :2209-2216
[5]   National Trends in Heart Failure Hospitalization After Acute Myocardial Infarction for Medicare Beneficiaries 1998-2010 [J].
Chen, Jersey ;
Hsieh, Angela Fu-Chi ;
Dharmarajan, Kumar ;
Masoudi, Frederick A. ;
Krumholz, Harlan M. .
CIRCULATION, 2013, 128 (24) :2577-2584
[6]   Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials [J].
Collins, R ;
MacMahon, S .
LANCET, 2001, 357 (9253) :373-380
[7]  
Cowie MR, 1997, EUR HEART J, V18, P208
[8]   The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure [J].
Curtis, JP ;
Sokol, SI ;
Wang, YF ;
Rathore, SS ;
Ko, DT ;
Jadbabaie, F ;
Portnay, EL ;
Marshalko, SJ ;
Radford, MJ ;
Krumholz, HM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) :736-742
[9]   Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure - A report from the OPTIMIZE-HF registry [J].
Fonarow, Gregg C. ;
Stough, Wendy Gattis ;
Abraham, William T. ;
Albert, Nancy M. ;
Gheorghiade, Mihai ;
Greenberg, Barry H. ;
O'Connor, Christopher M. ;
Sun, Jie Lena ;
Yancy, Clyde W. ;
Young, James B. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (08) :768-777
[10]   Acute heart failure syndromes -: Current state and framework for future research [J].
Gheorghiade, M ;
Zannad, F ;
Sopko, G ;
Klein, L ;
Piña, IL ;
Konstam, MA ;
Massie, BM ;
Roland, E ;
Targum, S ;
Collins, SP ;
Filippatos, G ;
Tavazzi, L .
CIRCULATION, 2005, 112 (25) :3958-3968